Who owns Neurocrine Biosciences?

Key details on Neurocrine Biosciences (Ticker: NBIX)

Who owns Neurocrine Biosciences?

Is NBIX a good stock to own? Find out who bought Neurocrine Biosciences, who sold Neurocrine Biosciences (NBIX) stock, and who holds a large position in Neurocrine Biosciences.

Fund Name Number of Shares Share Valuation As Of
FMR 11.39M $178.45M Sept. 30, 2014
T. Rowe Price Associates 10.26M $152.19M June 30, 2014
BVF 5.93M $50.40M Dec. 31, 2011
OrbiMed Advisors 5.79M $90.79M Sept. 30, 2014
Perceptive Advisors 5.22M $81.77M Sept. 30, 2014
BB Biotech AG 3.12M $48.84M Sept. 30, 2014
BlackRock Fund Advisors 2.56M $40.07M Sept. 30, 2014
Vanguard 2.28M $35.79M Sept. 30, 2014
STATE STREET CORPORATION 2.22M $34.71M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 2.08M $32.53M Sept. 30, 2014
VHCP Management 1.96M $26.29M June 30, 2013
S.A.C. Capital Advisors 1.88M $14.07M Dec. 31, 2012
Franklin Resources 1.84M $28.81M Sept. 30, 2014
Visium Asset Management 1.79M $28.01M Sept. 30, 2014
Jennison Associates 1.64M $18.59M Sept. 30, 2013
Dr. Jeffrey R. Jay, M.D. 1.51M $22.42M June 30, 2014
Hambrecht & Quist Capital Management 1.48M $11.09M Dec. 31, 2012

Who sold Neurocrine Biosciences?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wellington Management Company June 30, 2011 1.93M $15.56M